The Dutch Arthritis Society supports further development of the meniscus prosthesis of ATRO Medical
Orthopedic startup ATRO Medical enters a partnership together with the Dutch Arthritis Society for further development of the artificial meniscus. The Dutch startup works on a meniscus prosthesis for people with knee arthritis. The Dutch Arthritis Society supports these developments and shares its experience as patient expert in the field of arthritis.
10 years ago, the Dutch Arthritis Society has invested in new materials for the research done by Radboud University Medical Center. Which changed the positioning of the health fund together with diverse universities and royal DSM to the upfront of new approach of Polycarbonate Urethan. Which the startup ATRO Medical originated in 2017, located on the Novio Tech campus in Nijmegen, The Netherlands. From there on out the accumulated scientifical knowledge was further developed into an applicable prothesis.
Jan Hunik, CEO of ATRO Medical: ‘’ Since 2019 the meniscus prosthesis has been used in clinical study with the first patients. The second clinical trial starts in 2021 with a couple of Dutch hospitals. The trials must lead to CE marking of the unique prosthesis especially due to the knowledge provided by Dutch Arthritis Society, which makes this innovation available for European patients.’’
The artificial meniscus prosthesis is meant for patients with knee arthritis. With many of these patients their meniscus was partially removed, or they’re experiencing chronic pain due to knee wear. The meniscus prosthesis offers this group of patients an alternative for the current policies such as pain medication, physiotherapy and the wait to being considered for a total knee replacement.
Corné Baatenburg de Jong of The Dutch Arthritis Society explains: ‘’It is nice to see that a development throughout the years has eventually been integrated by a team such the one of ATRO Medical and turned it into a new procedure for the patient. They work hard to improve the quality of knee arthritis patients with the use of the meniscus prosthesis. During the implementation, we as organization can support this. We know the way through the path. And thanks to the big patient participation at The Dutch Arthritis Society, we can make sure that their voices are heard. This guarantees that the development fits the patients’ expectations.
About ATRO Medical
ATRO Medical is a spin-off of DSM & Radboud University Medical Center with offices in Nijmegen & Uden (NL). The startup builds further on knowledge from the public-privates collaboration BioMedical Materials (BMM), started in 2010 as a consortium of universities and companies with financial support of the Dutch government. The collaboration between clinical, biomechanical & polymer-experts which led to development of the Meniscus Prosthesis and establishment of ATRO Medical in 2016. The first clinical study started in 2019. More information can be found on www.atromedical.com
Contacts
Maarten van der Zanden, CIO & Market Development manager
T: +316 3735 3787 E: maarten.vanderzanden@atromedical.com
Share this article
Do you want to read more?
View related articles here
Dutch meniscus prosthesis receives FDA Breakthrough Device Designation
Patients
Dutch medical innovations are rarely granted the Breakthrough Designation by the FDA. Startup ATRO Medical from Nijmegen is the new kid on the block in orthopedics. This week their Trammpolin® meniscus prosthesis (nowadays known as Artimis®), designed to treat chronic knee pain, received the Breakthrough Device Designation from the FDA. The designation demonstrates the innovation potential of this implant and expedites US market access by receiving a priority treatment at the FDA.
EUROSTARS grants funding for first lateral meniscus prosthesis
Professionals
An international consortium led by the Dutch med-tech startup ATRO Medical receives over € 800,000 EUROSTARS funding to address an unmet need for Knee Osteoarthritis patients. These patients often suffer from cartilage degradation related to a dysfunctional meniscus. Based on previous research, the consortium will develop a durable meniscus prosthesis for the outer knee compartment to relief pain and restore mobility. This would change the life of thousands of osteoarthritis patients.
ATRO Medical Named Awardee in the Johnson & Johnson Innovation Veterans Lead QuickFire Challenge
Professionals
Yess!! ATRO Medical has been named an Awardee in the Veterans Lead QuickFire Challenge organized by Johnson & Johnson Innovation!
The Dutch Arthritis Society supports further development of the meniscus prosthesis of ATRO Medical
Patients
Orthopedic startup ATRO Medical enters a partnership together with the Dutch Arthritis Society for further development of the artificial meniscus. The Dutch startup works on a meniscus prosthesis for people with knee arthritis. The Dutch Arthritis Society supports these developments and shares its experience as patient expert in the field of arthritis.
Meniscus prosthesis receives € 2.5 million EU grant
Professionals
The European Commission grants € 2.5 million to ATRO Medical for the accelerated development of their artificial meniscus. The Dutch startup works on the first anatomical meniscus prostheses for patients with chronic knee pain. Their ground-breaking innovation continues to attract international attention, paving the way towards full-scale healthcare implementation.
ATRO Medical B.V.
We are an innovative medical device company that was was founded in 2016. The lead product is the Artimis® meniscus prosthesis.
Contact details
Novio Tech Campus
Transistorweg 5, 6534 AT Nijmegen (Headquarters)
Liessentstraat 9a, 5405 AH Uden (Registered office)
info@atromedical.com
Navigation
Newsletter
Stay informed of the latest news and development regarding Artimis®!
